Cargando…

Integrated Plasma Metabolomics and Gut Microbiota Analysis: The Intervention Effect of Jiawei Xiaoyao San on Liver Depression and Spleen Deficiency Liver Cancer Rats

Primary liver cancer is the third most common malignancy, and hepatocellular carcinoma is its main subtype, with a high recurrence rate and high mortality. Intestinal microflora and metabolic disorders are present in most HCC patients. Traditional Chinese medicine (TCM) plays an important role in th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Zhuoxian, Zhao, Youxing, Cheng, Jinlai, Xu, Lijing, Wen, Xiaoyu, Sun, Yuhao, Xia, Meng, He, Yining
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9340265/ https://www.ncbi.nlm.nih.gov/pubmed/35924041 http://dx.doi.org/10.3389/fphar.2022.906256

Ejemplares similares

Jiawei Xiaoyao San in treatment of anxiety disorder and anxiety: A review
por: Xie, Jiaqi, et al.
Publicado: (2023)

Effectiveness and potential mechanism of Jiawei-Xiaoyao-San for hyperthyroidism: a systematic review
por: Ma, Wenxin, et al.
Publicado: (2023)

Anti-endometriosis Mechanism of Jiawei Foshou San Based on Network Pharmacology
por: Chen, Yi, et al.
Publicado: (2018)

An Herbal Formulation of Jiawei Xiaoyao for the Treatment of Functional Dyspepsia: A Multicenter, Randomized, Placebo-Controlled, Clinical Trial
por: Chen, Guang, et al.
Publicado: (2020)

The intervention effect of Aitongxiao prescription on primary liver cancer rats was evaluated based on high-throughput miRNA sequencing and bioinformatics analysis
por: Xu, Lijing, et al.
Publicado: (2023)

Safety and efficacy of Xiaoyao-san for the treatment of functional dyspepsia: a systematic review and meta-analysis of randomized controlled trials
por: Ha, Na-Yeon, et al.
Publicado: (2023)

Xiaoyao Pills Prevent Lipopolysaccharide-Induced Depression by Inhibiting Inflammation and Protecting Nerves
por: Shi, Boyu, et al.
Publicado: (2019)

Combining fecal microbiome and metabolomics to reveal the disturbance of gut microbiota in liver injury and the therapeutic mechanism of shaoyao gancao decoction
por: Li, Jingwei, et al.
Publicado: (2022)

Codonopsis pilosula Polysaccharide Improved Spleen Deficiency in Mice by Modulating Gut Microbiota and Energy Related Metabolisms
por: Cao, Lingya, et al.
Publicado: (2022)

Gut microbiota in alcohol-related liver disease: pathophysiology and gut-brain cross talk
por: Zhu, Lin, et al.
Publicado: (2023)

Disordered Gut Microbiota in Colorectal Tumor-Bearing Mice Altered Serum Metabolome Related to Fufangchangtai
por: Cai, Mengmeng, et al.
Publicado: (2022)

Danzhi Xiaoyao Powder Promotes Neuronal Regeneration by Downregulating Notch Signaling Pathway in the Treatment of Generalized Anxiety Disorder
por: Liu, Chao, et al.
Publicado: (2021)

Integrating Pharmacology and Gut Microbiota Analysis to Explore the Mechanism of Citri Reticulatae Pericarpium Against Reserpine-Induced Spleen Deficiency in Rats
por: Zheng, Yuying, et al.
Publicado: (2020)

Jiawei Runjing Decoction Improves Spermatogenesis of Cryptozoospermia With Varicocele by Regulating the Testicular Microenvironment: Two-Center Prospective Cohort Study
por: Liu, Huang, et al.
Publicado: (2022)

Gut microbiota-derived metabolites in inflammatory diseases based on targeted metabolomics
por: Xu, Hui, et al.
Publicado: (2022)

Pingwei San Ameliorates Spleen Deficiency-Induced Diarrhea through Intestinal Barrier Protection and Gut Microbiota Modulation
por: Fan, Yimeng, et al.
Publicado: (2023)

Vitamin C and vitamin D(3) alleviate metabolic-associated fatty liver disease by regulating the gut microbiota and bile acid metabolism via the gut-liver axis
por: Chen, Qingling, et al.
Publicado: (2023)

Efficacy, safety and mechanism of Honghua Xiaoyao Pill in the treatment of peri-menopausal syndrome: A study protocol for a randomized controlled trial
por: Wu, Xiao, et al.
Publicado: (2022)

Phillygenin Attenuates Carbon Tetrachloride-Induced Liver Fibrosis via Modulating Inflammation and Gut Microbiota
por: Wang, Cheng, et al.
Publicado: (2021)

Jiawei Foshou San Induces Apoptosis in Ectopic Endometrium Based on Systems Pharmacology, Molecular Docking, and Experimental Evidence
por: Wei, Jiahui, et al.
Publicado: (2019)

San-Huang-Yi-Shen Capsule Ameliorates Diabetic Nephropathy in Rats Through Modulating the Gut Microbiota and Overall Metabolism
por: Su, Xiuhai, et al.
Publicado: (2022)

Chaihu Shugan San ameliorated cognitive deficits through regulating gut microbiota in senescence-accelerated mouse prone 8
por: Li, Zhiyue, et al.
Publicado: (2023)

Mingmu Xiaoyao granules regulate the PI3K/Akt/mTOR signaling pathway to reduce anxiety and depression and reverse retinal abnormalities in rats
por: Ma, Qiuyan, et al.
Publicado: (2022)

Naturally Occurring TPE-CA Maintains Gut Microbiota and Bile Acids Homeostasis via FXR Signaling Modulation of the Liver–Gut Axis
por: Liu, Linlin, et al.
Publicado: (2020)

Gut metabolomics and 16S rRNA sequencing analysis of the effects of arecoline on non-alcoholic fatty liver disease in rats
por: Zhu, Lingping, et al.
Publicado: (2023)

Ginsenosides Improve Nonalcoholic Fatty Liver Disease via Integrated Regulation of Gut Microbiota, Inflammation and Energy Homeostasis
por: Liang, Wenyi, et al.
Publicado: (2021)

Ursodeoxycholic Acid Treatment Restores Gut Microbiota and Alleviates Liver Inflammation in Non-Alcoholic Steatohepatitic Mouse Model
por: Li, Hu, et al.
Publicado: (2021)

Kuhuang alleviates liver fibrosis by modulating gut microbiota-mediated hepatic IFN signaling and bile acid synthesis
por: Shen, Bo, et al.
Publicado: (2022)

Distinct common signatures of gut microbiota associated with damp-heat syndrome in patients with different chronic liver diseases
por: Pan, Yuqing, et al.
Publicado: (2022)

Gut Microbiota Combined With Metabolomics Reveals the Repeated Dose Oral Toxicity of β-Cyclodextrin in Mice
por: Lv, Shuangyu, et al.
Publicado: (2021)

Alterations in the gut microbiota and serum metabolomics of spontaneous cholestasis caused by loss of FXR signal in mice
por: Wei, Shizhang, et al.
Publicado: (2023)

Effectiveness and safety of Chinese herbal medicine Xiaoyao san for the treatment of insomnia: Protocol for a systematic review and meta-analysis
por: Li, Jiamin, et al.
Publicado: (2019)

The Mechanism of Xiaoyao San in the Treatment of Ovarian Cancer by Network Pharmacology and the Effect of Stigmasterol on the PI3K/Akt Pathway
por: Li, Meng, et al.
Publicado: (2021)

Modified xiaoyao san combined with chemotherapy for breast cancer: A systematic review and meta-analysis of randomized controlled trials
por: Pan, Junhua, et al.
Publicado: (2023)

Integrated network pharmacology and proteomics to reveal the cognitive improvement effect of Wuzang Wenyang Huayu decoction on vascular dementia
por: Sun, Yuhao, et al.
Publicado: (2022)

Altered gut microbiota–host bile acid metabolism in IBS-D patients with liver depression and spleen deficiency pattern
por: Du, Liqing, et al.
Publicado: (2023)

The Effect of Lithocholic Acid on the Gut-Liver Axis
por: Sheng, Wei, et al.
Publicado: (2022)

Network Pharmacological Analysis and Experimental Validation of the Mechanisms of Action of Si-Ni-San Against Liver Fibrosis
por: Wang, Siliang, et al.
Publicado: (2021)

Serum, spleen metabolomics and gut microbiota reveals effect of catalpol on blood deficiency syndrome caused by cyclophosphamide and acetylphenylhydrazine
por: Zhang, Wensen, et al.
Publicado: (2023)

Mechanism of Action of Xiaoyao San in Treatment of Ischemic Stroke is Related to Anti-Apoptosis and Activation of PI3K/Akt Pathway
por: Xu, Yue, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_090dicra3ghaa8po1ghp5cavsa